IDS and mucopolysaccharidosis type 2: In this study, we found that predicted changes over time in clinical parameters generally appeared to be similar in the groups of patients stratified by age at ERT start, suggesting that IV ERT with idursulfase may stabilize or improve somatic manifestations of MPS II regardless of when treatment is initiated.